Trademarks

©1996-2008, Mirus Bio Corporation, ExpressIT, HeLaMONSTER, HybQUEST, It All Begins at the Bench, Label IT, MiraCLEAN, μArray, pLIVE,Pathway IV, siQUEST, siXpress, SuppressIT, TransIT-Neural,TransIT-TKO and TransIT are registered trademarks of Mirus Bio Corporation. Dynamic PolyConjugates, Gene Transfer Specialists, Insecta, Insites, LOAD 'n GLO, Making the Complex Achievable and Tracker are trademarks of Mirus Bio Corporation.

Patent and Licensing Information

Mirus Bio TransIT® polyamine transfection reagents are covered by U.S. Patent No. 5,744,335, No. 6,180,784, and No. 6,458,382.

Mirus Bio Label IT® nucleic acid labeling and modifying reagents are covered by U.S. Patent No. 6,262,252, and No. 6,593,465. Cy™3 and Cy™5 products or portions thereof are manufactured under license from Carnegie Mellon University and are covered by U.S. Patent No. 5,268,486.

The pLIVE™ Vectors are covered by patents pending of Mirus Bio Corporation. Purchase of this product conveys a license for use of this product only for research by the purchaser in not-for-profit institutions. The purchaser may only transfer vectors modified with sequences for protein expression to researchers in not-for-profit institutions who agree to be bound by this license. This license does not include the right to perform research at or on behalf of a for-profit entity, the right to transfer unmodified vectors to others or the right to use the product for any commercial purpose (e.g. therapeutics, manufacturing, diagnostics or sale or fee-for-service use of animal models). Prospective users at for-profit institutions or those who wish to perform research on behalf of for-profit institutions or any other commercial purpose must contact Mirus Bio Corporation for a commercial license. If you require a commercial license to use this product and you decide not to take a license, please return the unopened product to Mirus Bio Corporation for a full refund.

In vivo hydrodynamic delivery of non-viral nucleic acids is covered by worldwide patents and patent applications of Mirus Bio Corporation, including U.S. Patent 6,627,616 and related filings worldwide. Purchase of these products does not provide a license to this delivery technology, which is required for all research and commercial uses by for-profit entities. To inquire about a license, please contact Mirus Bio Corporation.